Nocturnal Sleep-Wake Parameters of Adolescents at Home Following Cancer Chemotherapy

Amy J. Walker, Kyle Johnson, Christine Miaskowski, Vivian Gedaly-Duff

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: The purpose of this descriptive, longitudinal study was to describe objective nocturnal sleep-wake parameters of adolescents at home after receiving chemotherapy in the hospital or outpatient clinic and explore differences in sleep variables by age, gender, and corticosteroid use. Methods: We collected 7 days of wrist actigraphy and sleep diary data from 48 adolescents (10-19 years) who were receiving cancer chemotherapy for a primary or secondary cancer or a relapse. The actigraphic sleep variables included rest interval (i.e., time in bed), sleep onset, sleep offset, sleep duration, total sleep time (TST), wake after sleep onset (WASO), and %WASO. Results: Of the 48 adolescents, 38 had at least five nights of scored actigraphy and were included in analyses. Older (13-18 years) adolescents went to bed later and had fewer minutes of TST than younger adolescents (10-12 years). Exploratory analyses revealed no differences between adolescents who were taking oral corticosteroids (i.e., prednisone, dexamethasone) and those who were not or between males and females. Conclusion: These adolescents had sleep durations that met or exceeded the recommended sleep duration for their age groups but experienced significant WASO. Further research is needed to estimate sleep needs of adolescents during chemotherapy and determine factors that contribute to nocturnal wake-time so that targeted interventions can be designed to improve sleep quality.

Original languageEnglish (US)
Pages (from-to)236-241
Number of pages6
JournalBiological Research for Nursing
Volume14
Issue number3
DOIs
StatePublished - Jul 2012

Fingerprint

Sleep
Drug Therapy
Neoplasms
Actigraphy
Adrenal Cortex Hormones
Hospital Outpatient Clinics
Prednisone
Wrist
Dexamethasone
Longitudinal Studies
Age Groups

Keywords

  • adolescents
  • chemotherapy
  • sleep

ASJC Scopus subject areas

  • Research and Theory

Cite this

Nocturnal Sleep-Wake Parameters of Adolescents at Home Following Cancer Chemotherapy. / Walker, Amy J.; Johnson, Kyle; Miaskowski, Christine; Gedaly-Duff, Vivian.

In: Biological Research for Nursing, Vol. 14, No. 3, 07.2012, p. 236-241.

Research output: Contribution to journalArticle

Walker, Amy J. ; Johnson, Kyle ; Miaskowski, Christine ; Gedaly-Duff, Vivian. / Nocturnal Sleep-Wake Parameters of Adolescents at Home Following Cancer Chemotherapy. In: Biological Research for Nursing. 2012 ; Vol. 14, No. 3. pp. 236-241.
@article{1511244297e2413aa2bdf6d4bf2ec7de,
title = "Nocturnal Sleep-Wake Parameters of Adolescents at Home Following Cancer Chemotherapy",
abstract = "Purpose: The purpose of this descriptive, longitudinal study was to describe objective nocturnal sleep-wake parameters of adolescents at home after receiving chemotherapy in the hospital or outpatient clinic and explore differences in sleep variables by age, gender, and corticosteroid use. Methods: We collected 7 days of wrist actigraphy and sleep diary data from 48 adolescents (10-19 years) who were receiving cancer chemotherapy for a primary or secondary cancer or a relapse. The actigraphic sleep variables included rest interval (i.e., time in bed), sleep onset, sleep offset, sleep duration, total sleep time (TST), wake after sleep onset (WASO), and {\%}WASO. Results: Of the 48 adolescents, 38 had at least five nights of scored actigraphy and were included in analyses. Older (13-18 years) adolescents went to bed later and had fewer minutes of TST than younger adolescents (10-12 years). Exploratory analyses revealed no differences between adolescents who were taking oral corticosteroids (i.e., prednisone, dexamethasone) and those who were not or between males and females. Conclusion: These adolescents had sleep durations that met or exceeded the recommended sleep duration for their age groups but experienced significant WASO. Further research is needed to estimate sleep needs of adolescents during chemotherapy and determine factors that contribute to nocturnal wake-time so that targeted interventions can be designed to improve sleep quality.",
keywords = "adolescents, chemotherapy, sleep",
author = "Walker, {Amy J.} and Kyle Johnson and Christine Miaskowski and Vivian Gedaly-Duff",
year = "2012",
month = "7",
doi = "10.1177/1099800411408414",
language = "English (US)",
volume = "14",
pages = "236--241",
journal = "Biological Research for Nursing",
issn = "1099-8004",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Nocturnal Sleep-Wake Parameters of Adolescents at Home Following Cancer Chemotherapy

AU - Walker, Amy J.

AU - Johnson, Kyle

AU - Miaskowski, Christine

AU - Gedaly-Duff, Vivian

PY - 2012/7

Y1 - 2012/7

N2 - Purpose: The purpose of this descriptive, longitudinal study was to describe objective nocturnal sleep-wake parameters of adolescents at home after receiving chemotherapy in the hospital or outpatient clinic and explore differences in sleep variables by age, gender, and corticosteroid use. Methods: We collected 7 days of wrist actigraphy and sleep diary data from 48 adolescents (10-19 years) who were receiving cancer chemotherapy for a primary or secondary cancer or a relapse. The actigraphic sleep variables included rest interval (i.e., time in bed), sleep onset, sleep offset, sleep duration, total sleep time (TST), wake after sleep onset (WASO), and %WASO. Results: Of the 48 adolescents, 38 had at least five nights of scored actigraphy and were included in analyses. Older (13-18 years) adolescents went to bed later and had fewer minutes of TST than younger adolescents (10-12 years). Exploratory analyses revealed no differences between adolescents who were taking oral corticosteroids (i.e., prednisone, dexamethasone) and those who were not or between males and females. Conclusion: These adolescents had sleep durations that met or exceeded the recommended sleep duration for their age groups but experienced significant WASO. Further research is needed to estimate sleep needs of adolescents during chemotherapy and determine factors that contribute to nocturnal wake-time so that targeted interventions can be designed to improve sleep quality.

AB - Purpose: The purpose of this descriptive, longitudinal study was to describe objective nocturnal sleep-wake parameters of adolescents at home after receiving chemotherapy in the hospital or outpatient clinic and explore differences in sleep variables by age, gender, and corticosteroid use. Methods: We collected 7 days of wrist actigraphy and sleep diary data from 48 adolescents (10-19 years) who were receiving cancer chemotherapy for a primary or secondary cancer or a relapse. The actigraphic sleep variables included rest interval (i.e., time in bed), sleep onset, sleep offset, sleep duration, total sleep time (TST), wake after sleep onset (WASO), and %WASO. Results: Of the 48 adolescents, 38 had at least five nights of scored actigraphy and were included in analyses. Older (13-18 years) adolescents went to bed later and had fewer minutes of TST than younger adolescents (10-12 years). Exploratory analyses revealed no differences between adolescents who were taking oral corticosteroids (i.e., prednisone, dexamethasone) and those who were not or between males and females. Conclusion: These adolescents had sleep durations that met or exceeded the recommended sleep duration for their age groups but experienced significant WASO. Further research is needed to estimate sleep needs of adolescents during chemotherapy and determine factors that contribute to nocturnal wake-time so that targeted interventions can be designed to improve sleep quality.

KW - adolescents

KW - chemotherapy

KW - sleep

UR - http://www.scopus.com/inward/record.url?scp=84862294381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862294381&partnerID=8YFLogxK

U2 - 10.1177/1099800411408414

DO - 10.1177/1099800411408414

M3 - Article

C2 - 21613338

AN - SCOPUS:84862294381

VL - 14

SP - 236

EP - 241

JO - Biological Research for Nursing

JF - Biological Research for Nursing

SN - 1099-8004

IS - 3

ER -